Retracted: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway

Detalles Bibliográficos
Autores principales: Zhang, Fengli, Chen, Huixiao, Du, Jing, Wang, Bin, Yang, Lixiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009266/
https://www.ncbi.nlm.nih.gov/pubmed/33762564
http://dx.doi.org/10.12659/MSM.932331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009266/
https://www.ncbi.nlm.nih.gov/pubmed/33762564
http://dx.doi.org/10.12659/MSM.932331

Ejemplares similares